Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta-analysis

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 1022-1030

  Li, Hui ^a,b   Fu, Wei Ping ^c   Hong, Ze Hui ^a,b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Meta analysis; Microsomal epoxide hydrolase gene; Polymorphism

Indexed keywords

EPOXIDE HYDROLASE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA POLYMORPHISM; DNA SEQUENCE; ENZYME ACTIVITY; ETHNIC AND RACIAL GROUPS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SMOKING;

EID: 84872701575     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1099     Document Type: Article

References (43)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR and Hurd SS; GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276, 2001.
2. Fabbri L, Caramori G, Beghe B, Papi A and Ciaccia A: Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med 4: 76-84, 1998.
3. Løkke A, Lange P, Scharling H, Fabricius P and Vestbo J: Developing COPD: a 25 year follow up study of the general population. Thorax 61: 935-939, 2006.
4. Silverman EK, Chapman HA, Drazen JM, et al: Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 157: 1770-1778, 1998.
5. Foreman MG, DeMeo DL, Hersh CP, Reilly JJ and SilvermanEK: Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J 30: 1124-1130, 2007.
6. Oesch F, Glatt H and Schmassmann H: The apparent ubiquity of epoxide hydratase in rat organs. Biochem Pharmacol 26: 603-607, 1977.
7. Omiecinski CJ, Aicher L, Holubkov R and Checkoway H: Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3: 150-158, 1993.
8. Hassett C, Aicher L, Sidhu JS and Omiecinski CJ: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421-428, 1994.
9. Smith CA and Harrison DJ: Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350: 630-633, 1997.
10. Takeyabu K, Yamaguchi E, Suzuki I, Nishimura M, Hizawa N and Kamakami Y: Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur Respir J 15: 891-894, 2000.
11. Yim JJ, Park GY, Lee CT, et al: Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 55: 121-125, 2000.
12. Rodriguez F, Jardi R, Costa X, et al: Detection of polymorphisms at exons 3 (Tyr113-->His) and 4 (His139-->Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis. Anal Biochem 308: 120-126, 2002.
13. Korytina GF, Ianbaeva DG and Viktorova TV: Role of polymorphic variants of cytochrome P450 genes (CYP1A1, CYP2E1) and microsomal epoxide hydrolase (mEPHX) in pathogenesis of cystic fibrosis and chronic respiratory tract diseases. Mol Biol (Mosk) 37: 784-792, 2003 (In Russian).
14. Cheng SL, Yu CJ, Chen CJ and Yang PC: Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 23: 818-824, 2004.
15. Xiao D, Wang C, Du MJ, et al: Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin Med J (Engl) 117: 661-667, 2004.
16. Hersh CP, Demeo DL, Lange C, et al: Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 33: 71-78, 2005.
17. Brøgger J, Steen VM, Eiken HG, Gulsvik A and Bakke P: Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 27: 682-688, 2006.
18. Fu WP, Sun C, Dai LM, Yang LF and Zhang YP: Relationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese population. Oncol Rep 17: 483-488, 2007.
19. Vibhuti A, Arif E, Deepak D, Singh B and Qadar Pasha MA: Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun 359: 136-142, 2007.
20. Zhang RB, Zhang AZ, He QY and Lu BB: Microsomal epoxide hydrolase gene polymorphism and susceptibility to chronic obstructive pulmonary disease in Han nationality of North China. Zhonghua Nei Ke Za Zhi 41: 11-14, 2002 (In Chinese).
21. Zheng Q and Zheng W: The association between the microsomal epoxide hydrolase gene polymorphism and host's susceptibility to COPD. Chin J Prim Med Pham (Chin) 16: 1779-1780, 2009 (In Chinese).
22. Zidzik J, Slabá E, Joppa P, et al: Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J 49: 182-191, 2008.
23. Chappell S, Daly L, Morgan K, et al: Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J 32: 931-937, 2008.
24. Lakhdar R, Denden S, Knani J, et al: Microsomal epoxide hydrolase gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in the Tunisian population. Genet Test Mol Biomarkers 14: 857-863, 2010.
25. Penyige A, Poliska S, Csanky E, et al: Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study. BMC Med Genet 11: 152, 2010.
26. Lee J, Nordestgaard BG and Dahl M: EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis. Eur Respir J 37: 18-25, 2011.
27. Chen CZ, Wang RH, Lee CH, Lin CC, Chang HY and Hsiue TR: Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response. J Formos Med Assoc 110: 685-689, 2011.
28. Budhi A, Hiyama K, Isobe T, et al: Genetic susceptibility for emphysematous changes of the lung in Japanese. Int J Mol Med 11: 321-329, 2003.
29. Park JY, Chen L, Wadhwa N and Tockman MS: Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. Int J Mol Med 15: 443-448, 2005.
30. Yoshikawa M, Hiyama K, Ishioka S, Maeda H, Maeda A and Yamakido M: Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med 5: 49-53, 2000.
31. Matheson MC, Raven J, Walters EH, Abramson MJ and Ellis JA: Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum Biol 78: 705-717, 2006.
32. Park SS, Kim EJ, Son CY, et al: Genetic polymorphism of epoxide hydrolase and GSTM1 in chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul) 55: 88-97, 2003.
33. Hu G, Shi Z, Hu J, Zou G, Peng G and Ran P: Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses. Respirology 13: 837-850, 2008.
34. Cochran WG: The combination of estimates from different experiments. Biometrics 10: 101-129, 1954.
35. Kavvoura FK and Ioannidis JP: Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 123: 1-14, 2008.
36. Colhoun HM, McKeigue PM and Davey Smith G: Problems of reporting genetic associations with complex outcomes. Lancet 361: 865-872, 2003.
37. Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.
38. DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
39. Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101, 1994.
40. Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
41. Zhou W, Thurston SW, Liu G, et al: The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol Biomarkers Prev 10: 461-466, 2001.
42. Maekawa K, Itoda M, Hanioka N, et al: Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects. Xenobiotica 33: 277-287, 2003.
43. Smolonska J, Wijmenga C, Postma DS and Boezen HM: Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med 180: 618-631, 2009.